| ★ | First Oral Therapy for #HidradenitisSuppurativa in Phase 3 | | 344 | Estados Unidos | |
| 11 | DERMATÓLOGA EXPLICA TODO SOBRE LOS POLINUCLEÓTIDOS Y LOS EXOSOMAS: NUEVOS TRATAMIENTOS FLACIDEZ | Dermisphere Dra. Leire Barrutia @dermisphere | 4.5K | — | 85 |
| 9 | Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata | | 611 | Estados Unidos | 85 |
| 16 | #REACTION PROTOCOLLO ANTI-CELLULITE 🔥"La tua estetista NON vuole che tu veda questo!" 👀 | 𝐆𝐢𝐨𝐯𝐚𝐧𝐧𝐢 𝐌𝐚𝐬𝐬𝐚𝐫𝐢 | 𝐇𝐞𝐚𝐥𝐭𝐡𝐲 𝐂𝐨𝐚𝐜𝐡𝐢𝐧𝐠 @giovannimassariwellnesscoach | 243 | Italia | 83 |
| 1 | Results from the First Oral Phase 3 Therapy for #HidradenitisSuppurativa | | 210 | Estados Unidos | 99 |
| 14 | Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing | | 209 | Estados Unidos | 84 |
| 15 | How Much Hair Regrowth Did Upadacitinib Achieve in Severe Alopecia Areata? | | 196 | Estados Unidos | 84 |
| 20 | What Comes Next for PORT-77 as It Heads Toward Phase 2b/3? | | 196 | Estados Unidos | 83 |
| 2 | Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD | | 172 | Estados Unidos | 94 |
| 7 | How Upadacitinib Could Expand Options for Severe Alopecia Areata, With Natasha Mesinkovska, MD, PhD | | 93 | Estados Unidos | 85 |
| 17 | What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis? | | 92 | Estados Unidos | 83 |
| 12 | What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata | | 82 | Estados Unidos | 84 |
| 5 | Bimekizumab Data Support Case for Earlier Intervention in HS | | 78 | Estados Unidos | 87 |
| 3 | STOP-HS: Povorcitinib Shows Durable Response in HS at Week 54 | | 60 | Estados Unidos | 93 |
| 8 | Age-Stratified Phase 3 Data Support Tapinarof Cream in Pediatric Eczema | | 58 | Estados Unidos | 85 |
| 18 | ADorable-1 Results: Key Findings in Pediatric Atopic Dermatitis | | 58 | Estados Unidos | 83 |
| 19 | DESCUBRE EL TRATAMIENTO FACIAL: pH FACIAL EQUILIBRANTE | | 49 | España | 83 |
| 13 | Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA | | 30 | Estados Unidos | 84 |
| 6 | Discussing Raising HS Awareness and Treatments, With Kiera Booth, MD | | 20 | Estados Unidos | 85 |
| 4 | BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS | | 14 | Estados Unidos | 88 |
| 10 | Delgocitinib & Hand Eczema: How Topical JAK Inhibitors Change the Treatment Sequence | Maui Derm | | 11 | Estados Unidos | 85 |